Abbott Laboratories said yesterday that it had agreed to acquire the diagnostic-products maker International Murex Technologies Corporation for $13 a share, or $234 million. The tender offer, made directly to shareholders, was approved by the boards of both companies. International Murex, based in Toronto, had 1997 revenues of $106 million. Shares of International Murex rose nearly 19 percent, gaining $2 each, to $12.6875 in Nasdaq trading. Abbott, a medical products company based in Abbott Park, Ill., had 1997 sales of $11.9 billion.
